Kiora Pharmaceuticals (KPRX) Misses Q3 EPS by 81c

Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 EPS of ($0.81).

For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Bernstein upgrades Analog Devices on Q3 beat, improving risk-reward
• U.S 30-Year Treasuries Erase Gains Related to Yesterday's Buyback Announcement